Self-reported vitamin supplementation in early pregnancy and risk of miscarriage

American Journal of Epidemiology

Volumn 169, Issue 11, 2009, Pages 1312-1318

  Hasan, Reem ^a   Olshan, Andrew F ^a,b   Herring, Amy H ^a,b   Savitz, David A ^c   Siega Riz, Anna Maria ^a,b   Hartmann, Katherine E ^d  

^a The University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Abortion, spontaneous; Pregnancy trimester, first; Vitamins

Indexed keywords

PROGESTERONE; VITAMIN;

ABORTION; DRUG USER; HEALTH RISK; PREGNANCY; VITAMIN; WOMENS HEALTH;

ADULT; ARTICLE; DRUG USE; EDUCATION; ETHNIC DIFFERENCE; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MARRIAGE; MATERNAL AGE; MATERNAL NUTRITION; MATERNAL SMOKING; MODEL; PREGNANCY; RACE DIFFERENCE; RISK FACTOR; SELF REPORT; SPONTANEOUS ABORTION; VITAMIN SUPPLEMENTATION;

ABORTION, SPONTANEOUS; ADULT; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; ULTRASONOGRAPHY, PRENATAL; VITAMINS;

NORTH AMERICA; UNITED STATES;

EID: 66249134612     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp050     Document Type: Article

References (23)

1. Lumley J, Watson L, Watson M, et al. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects [electronic article]. Cochrane Database Syst Rev. 2001;(3):CD001056.
2. Centers for Disease Control and Prevention. Use of supplements containing folic acid among women of childbearing age - United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(1):5-8.
3. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341(20):1485-1490.
4. Nilsen RM, Vollset SE, Gjessing HK, et al. Patterns and predictors of folic acid supplement use among pregnant women: The Norwegian Mother and Child Cohort Study. Am J Clin Nutr. 2006;84(5):1134-1141.
5. Rosenberg KD, Gelow JM, Sandoval AP. Pregnancy intend-edness and the use of periconceptional folic acid. Pediatrics. 2003; 111 (5): 1142-1145.
6. Scholl TO, Hediger ML, Bendich A, et al. Use of multivitamin/ mineral prenatal supplements: influence on the outcome of pregnancy. Am J Epidemiol. 1997;146(2):134-141.
7. Vahratian A, Siega-Riz AM, Savitz DA, et al. Multivitamin use and the risk of preterm birth. Am J Epidemiol. 2004; 160(9): 886-892.
8. Catov JM, Bodnar LM, Ness RB, et al. Association of peri-conceptional multivitamin use and risk of preterm or small-for-gestational-age births. Am J Epidemiol. 2007;166(3): 296-303.
9. Bodnar LM, Tang G, Ness RB, et al. Periconceptional multivitamin use reduces the risk of preeclampsia. Am J Epidemiol. 2006;164(5):470-477.
10. Fawzi WW, Msamanga GI, Urassa W, et al. Vitamins and perinatal outcomes among HIV-negative women in Tanzania. N Engl J Med. 2007;356(14): 1423-1431.
11. Windham GC, Shaw GM, Todoroff K, et al. Miscarriage and use of multi-vitamins or folic acid. Am J Med Genet. 2000; 90(3):261-262.
12. George L, Granath F, Johansson AL, et al. Risks of repeated miscarriage. Paediatr Perinat Epidemiol. 2006;20(2): 119-126.
13. Rumbold A, Middleton P, Crowther CA. Vitamin supplementation for preventing miscarriage [electronic article]. Cochrane Database Syst Rev. 2005;(2):CD004073.
14. Hook EB, Czeizel AE. Can terathanasia explain the protective effect of folic-acid supplementation on birth defects? Lancet. 1997;350(9076):513- 515.
15. Gindler J, Li Z, Berry RJ, et al. Folic acid supplements during pregnancy and risk of miscarriage. Lancet. 2001;358(9284): 796-800.
16. George L, Mills JL, Johansson AL, et al. Plasma folate levels and risk of spontaneous abortion. JAMA. 2002;288(15): 1867-1873.
17. Kumar KS, Govindaiah V, Naushad SE, et al. Plasma homocysteine levels correlated to interactions between folate status and methylene tetrahydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss. J Obstet Gynaecol. 2003;23(1):55-58.
18. Ronnenberg AG, Goldman MB, Chen D, et al. Preconception folate and vitamin B(6) status and clinical spontaneous abortion in Chinese women. Obstet Gynecol. 2002;100(1):107-113.
19. Quéré I, Mercier E, Bellet H, et al. Vitamin supplementation and pregnancy outcome in women with recurrent early pregnancy loss and hyperhomocysteinemia. Fertil Steril. 2001; 75(4):823-825.
20. Nelen WL, Blom HJ, Steegers EA, et al. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol. 2000;95(4):519-524.
21. Nelen WL, Blom HJ, Thomas CM, et al. Methylenetetra-hydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr. 1998;128(8):1336-1341.
22. Sutterlin M, Bussen S, Ruppert D, et al. Serum levels of folate and cobalamin in women with recurrent spontaneous abortion. Hum Reprod. 1997;12(10):2292-2296.
23. Savitz DA, Dole N, Kaczor D, et al. Probability samples of area births versus clinic populations for reproductive epidemiology studies. Paediatr Perinat Epidemiol. 2005;19(4):315-322.